CME Group Inc. (NASDAQ:CME – Get Free Report) CEO Terrence Duffy sold 27,000 shares of CME Group stock in a transaction dated Wednesday, November 18th. The shares were sold at an average price of $309.57, for a total transaction of $8,358,390.00. Following the completion of the sale, the chief executive officer owned 35,442 shares in the company, valued at approximately $10,971,779.94. This trade represents a 43.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
CME Group Stock Down 1.3%
CME stock opened at $306.31 on Friday. The stock has a market capitalization of $109.64 billion, a P/E ratio of 25.13, a P/E/G ratio of 3.79 and a beta of 0.15. The firm has a 50-day simple moving average of $288.79 and a 200-day simple moving average of $282.00. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping the consensus estimate of $2.99 by $0.03. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The company’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.68 EPS. Equities analysts forecast that CME Group Inc. will post 12.35 earnings per share for the current fiscal year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group’s payout ratio is 42.66%.
Key Headlines Impacting CME Group
These are some of the CME headlines that stood out recently:
- Neutral Sentiment: CEO Terrence Duffy discussed CME Group’s Tour Championship and prediction markets in a media interview, but the coverage provided no specific financial or business update. Article
- Negative Sentiment: Duffy sold 27,000 shares for about $8.36 million, reducing his direct stake by 43.24%. General Counsel John Clifford Marchese also sold 655 shares, an 18.20% reduction in his holdings. Insider sales can be made for personal reasons and do not necessarily signal a change in company outlook, but the CEO’s sale may weigh on sentiment. CEO filing General counsel filing
- Negative Sentiment: A valuation-focused report says CME shares may be fully valued after a 69% run, raising the risk that expectations are already reflected in the price. Article
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the company. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. Barclays lifted their price target on CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 22nd. Morgan Stanley boosted their price target on CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. JPMorgan Chase & Co. raised CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price objective for the company in a research note on Thursday, October 22nd. Finally, UBS Group raised their price objective on CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a report on Thursday, October 22nd. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $314.44.
Check Out Our Latest Report on CME Group
Institutional Trading of CME Group
Large investors have recently bought and sold shares of the business. BlackRock Inc. purchased a new position in CME Group in the 2nd quarter worth approximately $6,749,965,000. Bank of New York Mellon Corp acquired a new position in shares of CME Group during the 2nd quarter worth approximately $867,313,000. Alphabet Inc. purchased a new stake in shares of CME Group in the second quarter valued at approximately $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of CME Group in the second quarter valued at approximately $629,771,000. Finally, Bank of America Corp DE purchased a new stake in shares of CME Group in the second quarter valued at approximately $622,679,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
About CME Group
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
